| Specialty Retail Industry | Consumer Discretionary Sector | Mr. Young-Joo Kim CEO | KRX SM Exchange | KR7185750007 ISIN |
| KR Country | 2,253 Employees | 29 Dec 2025 Last Dividend | 27 Dec 2024 Last Split | - IPO Date |
Chong Kun Dang Pharmaceutical Corp., established in 1941 and based in Seoul, South Korea, operates in the pharmaceutical industry both domestically and internationally. The company dedicates itself to the manufacturing, marketing, and sales of a wide range of medicines. Chong Kun Dang Pharmaceutical Corp. has carved out a reputable position in the market by offering a diverse portfolio of prescription drugs, over-the-counter medications, health supplements, and consumer health products. Alongside its prominent presence in the South Korean pharmaceutical market, the company also engages in exporting its products to various countries, showcasing its global outreach and the international trust in its offerings.